Illumina, Inc. (ILMN)

403.05
13.00 3.30
NASDAQ
Prev Close 390.21
Open 389.95
Day Low/High 389.95 / 404.07
52 Wk Low/High 196.78 / 404.20
Volume 1.38M
Exchange NASDAQ
Shares Outstanding 146.00B
Market Cap 56.97B
P/E Ratio 90.54
Div & Yield N.A. (N.A)
Are Drug Stocks What's Ailing the Market?

Are Drug Stocks What's Ailing the Market?

This move in health care takes your breath away.

Jared Woodard Intermediate Trade: IBB

Jared Woodard Intermediate Trade: IBB

Take advantage of elevated option premiums to gain long exposure to biotech.

Illumina Plummets on Weak Sales Forecast; Biotech Stocks Fall

Illumina Plummets on Weak Sales Forecast; Biotech Stocks Fall

DNA sequencing company Illumina (ILMN) plummeted in midday trading Tuesday after reporting disappointing preliminary sales for its third quarter.

Illumina Dims, but It's Still Set Up to Shine

With such a commanding lead in the sequencing business the stock can't stay down for long.

Illumina downgraded at Leerink

Illumina added to Focus List at Citi

Apple, Microsoft Sink Stocks; Baker Hughes' Volatile Afternoon

Apple, Microsoft Sink Stocks; Baker Hughes' Volatile Afternoon

Apple (AAPL) and Microsoft (MSFT) dragged on benchmark indexes.

Market Wrap: IBM and United Tech a Real Drag

Market Wrap: IBM and United Tech a Real Drag

IBM and UTX accounted for two-thirds of the Dow's 1% drop, and Apple and Microsoft fall after-hours..

Market Is Showing Its Underlying Weakness

Market Is Showing Its Underlying Weakness

Indices haven't reflected stocks' overall health.

Bright Idea: Take Some Illumina Off The Table

Bright Idea: Take Some Illumina Off The Table

After a strong run for the maker of scientific tools, investors may be vulnerable to a correction.

Here Are 3 Charts Showing You Why Illumina Is a Marvel

Here Are 3 Charts Showing You Why Illumina Is a Marvel

It's almost impossible to get too excited about its success.

Can Biotechs' Relative Strength Be Trusted? 6 Stocks to Watch

Can Biotechs' Relative Strength Be Trusted? 6 Stocks to Watch

Sector may not be as bulletproof as we thought.

Momentum Is Not Dead

The chasing in certain areas was intense.

Those Sensitive Biotechs

They are prone to being whipsawed by news.

Stick With the Price Action

It's the only way to deal with this market.

The Power of Momentum Won

Trends have a great tendency to persist.

The Uptrend Is Back

And no one thinks it's going to be easy to navigate.

Illumina estimates, target raised at JMP

Illumina upgraded at Piper

Stay Far Away From These Hot Potatoes

Stay Far Away From These Hot Potatoes

Here are three stocks to avoid at current levels.

Illumina upgraded at Wedbush

Illumina upgraded at Maxim

That Was the Week That Was

That Was the Week That Was

Let's review.

Decoding Illumina (Part 2)

Decoding Illumina (Part 2)

I'd wait until the stock cools off to buy shares.

Decoding Illumina (Part 1)

Decoding Illumina (Part 1)

Its genetics work has the stock at crazy new heights

Budget, Fannie-Freddie Reform Could Boost Defense, Medical, Housing

Budget, Fannie-Freddie Reform Could Boost Defense, Medical, Housing

Washington will offer mixed bag answers to key policy questions.